Strata Critical Medical (SRTA): CEO received 2,658 shares

2,658

Shares

Traded

Jul 30, 2026

Filed

Oct 30, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

What came next

1. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
2. Oct 15, 20265% stakeThird Point LLC filed an activist stake (13D) of 5.8%
3. Nov 3, 2026Company filing · Form 8-K · ResultsReported its results
4. Nov 5, 2026Insider · First insider buy since Jun 2024Director purchased ~$10K of SRTA shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Strata Critical Medical

For Strata Critical Medical, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SRTA page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Strata Critical Medical

• SEC Form 13F-HRNov 13, 2026
• SEC Form 4Nov 9, 2026
• SEC Schedule 13DOct 15, 2026
• SEC Form 144Oct 2, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 12, 2026

Everything OQRO holds on this company is on its SRTA page.